Subscribe to our press releases
ChromoGenics receives first order for Paragon to a value of 4,5 MSEK.
Real estate company Ticon Broen AS in Norway has chosen ConverLight Paragon for the project Ticon Drammen to a value of 4,5 MSEK.
With ConverLight Paragon ChromoGenics has created a façade glass that combines the unique ability of the dynamic glass to shift transparency in line after the sun light with world class insulating capacity. Those properties were highly valued by the real estate company Ticon Broen AS when they decided to place the order. Deliveries are scheduled to start May 2019.
“We are very happy to get an order for the world class product Paragon as soon as two weeks after release. It shows that we are on the right track”, says CEO Jerker Lundgren.
Jerker Lundgren, CEO
Lars Ericsson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
Certified Adviser: G&W Fondkommission, e-mail: email@example.com, tel.: +46 (0) 8 503 000 50
This information constitutes such information that ChromoGenics AB (publ) is obligated to disclose in accordance with the EU Market Abuse Regulation. The information was submitted by the above-mentioned contact persons for publication on 22 February, 2019, at 08:30 CET.
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
ChromoGenics offers dynamic glass with controllable heat- and light transmission and static glass with world leading performance. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.